About Pancreatic Cancer
The number of people diagnosed with pancreatic cancer in 2017 was 53,670. The average life span after diagnosis is only six months and 71% of those diagnosed will not survive more than one year. The five year survival rate is less than 9%. Pancreatic cancer, currently the 3rd leading cause of cancer death, is expected to become the 2nd by 2020. In spite of the number of people affected by the staggering mortality rate of this disease which is higher than all other major cancers, research funding for pancreatic cancer is shockingly inadequate; having remained largely unchanged for the past 40 years.
Our mission is to both raise money for pancreatic cancer research and treatment as well as make people aware of the funding needs. Currently, Pancreatic Cancer receives:
- Less than 2% of the National Cancer Institute’s (NCI) research budget
- Slightly more than $100 million from the federal government, while AIDS, affecting 40,000 new US residents each year, is appropriated more than $3 billion
All of the funds from this event will go to Jefferson University Hospital in Philadelphia, PA. This is the leading pancreatic cancer research and treatment hospital in our region, and where Amy received her treatment. The funds will be allocated between research and treatment. The portion going towards treatment will be donated to a fund which provides interim treatment to patients who are uninsured or underinsured until more permanent sources of coverage are found. Amy was a beneficiary of this fund which allowed her to receive immediate and critical treatment until she was able to secure coverage.
To donate via check
Make check payable to: “Pan-Cure”
PO Box 722
Quakertown, PA 18951